The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down, the drug maker has said.
Weight-loss drug demand opens new markets for Tasmania's poppy growers
As Tasmania's poppy industry celebrates 50 years, demand for weight-loss treatments is opening up new markets.
GPs concerned pharmacy prescribing extension could risk patient health
Doctors raise concerns over calls to extend a Victorian pilot program that allows patients to skip the GP and head straight to the pharmacy for some treatments.
What the major parties' health funding pledges mean for you
Just like Oprah's iconic "you get a car" moment, Labor is throwing urgent care clinics to punters like confetti.
Topic:Explainer
'Out of stock' prescription concerns for patients and providers
Have you gone to pick up a prescription only to find out it's not in stock? It's an issue across Australia, and things may not be getting better.
'A basic human right': Pain drug shortages cause problems in palliative care
Doctors often prescribe strong medications to relieve pain, distress and discomfort in palliative care, but many of these drugs have recently been unavailable or difficult to access.
American big pharma boss does not support tariffs on Australian medicines
The head of one of America's largest pharmaceutical companies says he does not support tariffs on Australian medicines as US President Donald Trump considers more trade restrictions.
Close to 500k Australians could have missed out on savings at the pharmacy
Nearly 500,000 Australians could be missing out on hundreds of dollars in savings at the pharmacy each year because of poor understanding and uptake of the country's "clunky" pharmaceutical safety net scheme.
Wondering what the PBS is? Your most common questions answered
You've probably heard a lot about something called the Pharmaceutical Benefits Scheme — or the PBS — this week. Here are some of your most commonly asked questions.
Topic:Explainer
Labor and Coalition vow PBS will not be bargained over in US trade war
Prime Minister Anthony Albanese and Opposition Leader Peter Dutton say the Pharmaceutical Benefits Scheme, a cornerstone of Australia's health system, will never be a negotiating chip in US President Donald Trump's ongoing tariff campaign.
PBS medication to cost no more than $25 under Labor re-election pitch
As US big pharma comes for Australia's PBS, Labor is promising even cheaper medicines.
Eating disorder hotline getting Ozempic queries raises concern
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
How Ozempic blunts food cravings — and our hankering for salty and sweet
People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food. This is how the drugs work.
Topic:Explainer
Call to subsidise diabetes monitor as type 2 patients face huge costs
Patients like Melanie Moor have to draw their own blood several times a day to check their glucose levels. There is an easier option — but few can afford it.
Ozempic shortage impacting regional Australians with diabetes
A nationwide shortage of Ozempic has left people living with type 2 diabetes without access to the drug, especially in the NT and regional areas.
Australians with diabetes feeling the squeeze from Ozempic shortage
Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.
ADHD diagnoses are skyrocketing but coaching can help
With more Australians than ever being diagnosed with ADHD, how do the treatments on offer stack up?
Purdue Pharma to pay billions to settle OxyContin crisis lawsuit
The pharmaceutical company's owners have agreed to pay US7.4 billion ($11.7 billion) and relinquish ownership of the company.
New tests at GP clinics could help fight resistance to antibiotics
The use of throat swabs and finger prick tests could provide rapid results, giving doctors more certainty before prescribing antibiotics.
Shortage of antipsychotic medication leaves mental health patients in limbo
An antipsychotic medication often prescribed to people with schizophrenia or bipolar is in short supply.
ABC Nationwide TV report from 1980 examined the risks and benefits of Depo-Provera.
Concerns about Depo-Provera date back to 1980. Since then, understanding of the drug's benefits and risks has expanded greatly.